Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trial

Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trial

Introduction: The combination of a fluoropyrimidine [5-fluorouracil (5-FU), capecitabine, or S-1] with a platinum analog (cisplatin or oxaliplatin) is the most widely accepted first-line chemotherapy regimen for metastatic or recurrent advanced gastric cancer (AGC), based on the results of clinical...

Full description

Bibliographic Details
Main Authors: Keun-Wook Lee, Dae Young Zang, Min-Hee Ryu, Ki Hyang Kim, Mi-Jung Kim, Hye Sook Han, Sung Ae Koh, Jin Hyun Park, Jin Won Kim, Byung-Ho Nam, In Sil Choi
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Contemporary Clinical Trials Communications
Subjects:
Gastric cancer
Elderly
Chemotherapy
Randomized controlled trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865417300911

Similar Items

Similar Items